Literature DB >> 21068804

Schizophrenia: The drug deadlock.

Alison Abbott.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21068804     DOI: 10.1038/468158a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  4 in total

1.  A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia.

Authors:  Robert W Buchanan; Miriam Davis; Donald Goff; Michael F Green; Richard S E Keefe; Andrew C Leon; Keith H Nuechterlein; Thomas Laughren; Robert Levin; Ellen Stover; Wayne Fenton; Steve R Marder
Journal:  Schizophr Bull       Date:  2005-02-16       Impact factor: 9.306

2.  The NIMH-MATRICS consensus statement on negative symptoms.

Authors:  Brian Kirkpatrick; Wayne S Fenton; William T Carpenter; Stephen R Marder
Journal:  Schizophr Bull       Date:  2006-02-15       Impact factor: 9.306

3.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

Authors:  Jeffrey A Lieberman; T Scott Stroup; Joseph P McEvoy; Marvin S Swartz; Robert A Rosenheck; Diana O Perkins; Richard S E Keefe; Sonia M Davis; Clarence E Davis; Barry D Lebowitz; Joanne Severe; John K Hsiao
Journal:  N Engl J Med       Date:  2005-09-19       Impact factor: 91.245

4.  Large recurrent microdeletions associated with schizophrenia.

Authors:  Hreinn Stefansson; Dan Rujescu; Sven Cichon; Olli P H Pietiläinen; Andres Ingason; Stacy Steinberg; Ragnheidur Fossdal; Engilbert Sigurdsson; Thordur Sigmundsson; Jacobine E Buizer-Voskamp; Thomas Hansen; Klaus D Jakobsen; Pierandrea Muglia; Clyde Francks; Paul M Matthews; Arnaldur Gylfason; Bjarni V Halldorsson; Daniel Gudbjartsson; Thorgeir E Thorgeirsson; Asgeir Sigurdsson; Adalbjorg Jonasdottir; Aslaug Jonasdottir; Asgeir Bjornsson; Sigurborg Mattiasdottir; Thorarinn Blondal; Magnus Haraldsson; Brynja B Magnusdottir; Ina Giegling; Hans-Jürgen Möller; Annette Hartmann; Kevin V Shianna; Dongliang Ge; Anna C Need; Caroline Crombie; Gillian Fraser; Nicholas Walker; Jouko Lonnqvist; Jaana Suvisaari; Annamarie Tuulio-Henriksson; Tiina Paunio; Timi Toulopoulou; Elvira Bramon; Marta Di Forti; Robin Murray; Mirella Ruggeri; Evangelos Vassos; Sarah Tosato; Muriel Walshe; Tao Li; Catalina Vasilescu; Thomas W Mühleisen; August G Wang; Henrik Ullum; Srdjan Djurovic; Ingrid Melle; Jes Olesen; Lambertus A Kiemeney; Barbara Franke; Chiara Sabatti; Nelson B Freimer; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Ole A Andreassen; Roel A Ophoff; Alexander Georgi; Marcella Rietschel; Thomas Werge; Hannes Petursson; David B Goldstein; Markus M Nöthen; Leena Peltonen; David A Collier; David St Clair; Kari Stefansson
Journal:  Nature       Date:  2008-09-11       Impact factor: 49.962

  4 in total
  28 in total

Review 1.  From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment.

Authors:  Bita Moghaddam; Daniel Javitt
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

Review 2.  Ketamine for treatment-resistant unipolar depression: current evidence.

Authors:  Sanjay J Mathew; Asim Shah; Kyle Lapidus; Crystal Clark; Noor Jarun; Britta Ostermeyer; James W Murrough
Journal:  CNS Drugs       Date:  2012-03-01       Impact factor: 5.749

3.  Reflections on the Innovative Medicines Initiative.

Authors:  Michel Goldman
Journal:  Nat Rev Drug Discov       Date:  2011-05       Impact factor: 84.694

4.  IMI moves forward.

Authors:  Rudolf Strohmeier; Ruxandra Draghia-Akli; Andrzej Rys; Pedro Ortun Silvan; Theodius Lennon; Carlo Incerti; Richard Bergström; Salahdine Chibout; Roch Doliveux; Peter Hongaard Andersen
Journal:  Nat Biotechnol       Date:  2011-08-05       Impact factor: 54.908

Review 5.  [Between psyche and brain : State of the art in psychiatry].

Authors:  T Fuchs
Journal:  Nervenarzt       Date:  2017-05       Impact factor: 1.214

Review 6.  Functional magnetic resonance imaging of intrinsic brain networks for translational drug discovery.

Authors:  Jason Smucny; Korey P Wylie; Jason R Tregellas
Journal:  Trends Pharmacol Sci       Date:  2014-06-03       Impact factor: 14.819

7.  A Computational Framework for Controlling the Self-Restorative Brain Based on the Free Energy and Degeneracy Principles.

Authors:  Hae-Jeong Park; Jiyoung Kang
Journal:  Front Comput Neurosci       Date:  2021-04-14       Impact factor: 2.380

8.  Probing thalamic integrity in schizophrenia using concurrent transcranial magnetic stimulation and functional magnetic resonance imaging.

Authors:  Yelena Guller; Fabio Ferrarelli; Alexander J Shackman; Simone Sarasso; Michael J Peterson; Frederick J Langheim; Mary E Meyerand; Giulio Tononi; Bradley R Postle
Journal:  Arch Gen Psychiatry       Date:  2012-07

Review 9.  Excitation-inhibition discoordination in rodent models of mental disorders.

Authors:  André A Fenton
Journal:  Biol Psychiatry       Date:  2015-03-18       Impact factor: 13.382

Review 10.  Preclinical models of antipsychotic drug action.

Authors:  José L Moreno; Javier González-Maeso
Journal:  Int J Neuropsychopharmacol       Date:  2013-06-10       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.